EPISODE · Jul 1, 2017 · 24 MIN

Scenesse FDA trials for vitiligo

from Understanding Vitiligo: Insights, Research, and Hope

Nathalie Pelletier speaks with Lachlan Hay, Head of Global Network and Communications at Clinuvel AG, and he explains exactly how Scenesse works on vitiligo.

Episode metadata supplied by the publisher feed · Published Jul 1, 2017

Embed this episode

Attribution link and audio player

NOW PLAYING

Scenesse FDA trials for vitiligo

0:00 24:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Understanding Vitiligo: Insights, Research, and Hope?

This episode is 24 minutes long.

When was this Understanding Vitiligo: Insights, Research, and Hope episode published?

This episode was published on July 1, 2017.

Can I download this Understanding Vitiligo: Insights, Research, and Hope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!